Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             117 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgements 2011
 71 S2 p. xiv-
1 p.
 artikel
2 Author index 2011
 71 S2 p. S53-S55
3 p.
 artikel
3 Drug reference list 2011
 71 S2 p. S59-
1 p.
 artikel
4 105 ECONOMICS OF LUNG CANCER TREATMENT: RESOURCE POOR NATIONS NEED NETWORKING OF NGOS WITH ESMO Shankpal, V.P.
 2011
 71 S2 p. S51-S52
2 p.
 artikel
5 Editorial Board 2011
 71 S2 p. ii-
1 p.
 artikel
6 European Multidisciplinary Conference in Thoracic Oncology Conference 2011 Officers and Organization 2011
 71 S2 p. xv-
1 p.
 artikel
7 3IN ADVANCED NSCLC Baas, P.
 2011
 71 S2 p. S3-
1 p.
 artikel
8 42IN ADVANCED NSCLC: MAINTENANCE WITH TARGETED THERAPIES Gridelli, C.
 2011
 71 S2 p. S24-
1 p.
 artikel
9 35IN ADVANCES IN SYSTEMIC THERAPY IN THE SPECTRUM OF NEUROENDOCRINE TUMOURS OF THE LUNG INCLUDING SMALL CELL LUNG CANCER Fr¨uh, M.
 2011
 71 S2 p. S20-S21
2 p.
 artikel
10 13IN A PATIENT WITH RESECTABLE NSCLC AND A SOLITARY SUSPECT ADRENAL LESION Thomas, M.
 2011
 71 S2 p. S8-S9
2 p.
 artikel
11 11IN A PATIENT WITH RESECTABLE RIGHT-SIDED NSCLC AND ONE SUSPECT NODULE ON THE LEFT SIDE Muelle, M.R.
 2011
 71 S2 p. S8-
1 p.
 artikel
12 12IN A PATIENT WITH RESECTABLE RIGHT-SIDED NSCLC AND SUSPECT RIGHT PARATRACHEAL LYMPH NODES Dooms, C.
 2011
 71 S2 p. S8-
1 p.
 artikel
13 39IN BEYOND EGFR, KRAS, ALK; WHAT ELSE? Mitsudomi, T.
 2011
 71 S2 p. S23-
1 p.
 artikel
14 38IN CHEMOTHERAPY SELECTION ACCORDING TO CHEMOTHERAPY BIOMARKERS Rosell, R.
 2011
 71 S2 p. S22-S23
2 p.
 artikel
15 1IN CLINICAL TRIALS AND TRANSLATIONAL RESEARCH IN EUROPE – THE ROLE OF ETOP Stahel, R.A.
 2011
 71 S2 p. S1-
1 p.
 artikel
16 2IN EARLY AND LOCALLY ADVANCED DISEASE Eberhardt, W.
 2011
 71 S2 p. S2-
1 p.
 artikel
17 5IN ESMO NON-SMALL-CELL LUNG CANCER (NSCLC) CONSENSUS ON PATHOLOGY AND MOLECULAR TESTING O'Byrne, K.
 2011
 71 S2 p. S4-
1 p.
 artikel
18 4IN ESMO RECOMMENDATION 2011: ADVANCED NSCLC Gridelli, C.
 2011
 71 S2 p. S3-
1 p.
 artikel
19 17IN FOLLOW-UP OF THE PATIENT AFTER CURATIVE TREATMENT Westeel, V.
 2011
 71 S2 p. S10-S11
2 p.
 artikel
20 8IN HOW TO SUB-CLASSIFY ADENOCARCINOMA OF THE LUNG Brambilla, E.
 2011
 71 S2 p. S6-
1 p.
 artikel
21 37IN HOW TREATMENT IS DONE NOW BASED ON EGFR/KRAS MUTATIONS AND ALK; STANDARD TREATMENT IN 2011 Reck, M.
 2011
 71 S2 p. S22-
1 p.
 artikel
22 16IN INCIDENTAL LUNG NODULES. WHAT DO YOU DO? Sculier, J.
 2011
 71 S2 p. S10-
1 p.
 artikel
23 34IN LOCAL THERAPY OF NEUROENDOCRINE TUMORS Stamatis, G.
 2011
 71 S2 p. S20-
1 p.
 artikel
24 41IN MAINTENANCE BY CHEMOTHERAPY Paz-Ares, L.
 2011
 71 S2 p. S24-
1 p.
 artikel
25 46IN MEDICAL ONCOLOGY – WHAT ARE THE REQUIREMENTS FOR A THORACIC ONCOLOGY CENTER? 2011
 71 S2 p. S25-
1 p.
 artikel
26 24IN MOLECULAR PATHOLOGY AND BIOLOGY IN EARLY NSCLC Besse, B.
 2011
 71 S2 p. S15-
1 p.
 artikel
27 10IN NEW TOOLS IN THE MOLECULAR DIAGNOSTIC OF LUNG CANCER Taron, M.
 2011
 71 S2 p. S7-
1 p.
 artikel
28 32IN NON-SURGICAL TREATMENT Daugaard, G.
 2011
 71 S2 p. S19-
1 p.
 artikel
29 30IN PATHOLOGY den Bakker, M.
 2011
 71 S2 p. S18-
1 p.
 artikel
30 36IN PERSONALISED TREATMENT ACCORDING TO AGE AND PERFORMANCE STATUS 2011
 71 S2 p. S22-
1 p.
 artikel
31 23IN PET-LABELED DRUGS Smit, E.
 2011
 71 S2 p. S14-
1 p.
 artikel
32 44IN PULMONOLOGY – WHAT ARE THE REQUIREMENTS FOR A THORACIC ONCOLOGY CENTER? Smit, E.
 2011
 71 S2 p. S25-
1 p.
 artikel
33 29IN RADIOFREQUENCY ABLATION FOR PULMONARY METASTASES Klomp, H.M.
 2011
 71 S2 p. S17-
1 p.
 artikel
34 45IN RADIOTHERAPY – WHAT ARE THE REQUIREMENTS FOR A THORACIC ONCOLOGY CENTER? Zips, D.
 2011
 71 S2 p. S25-
1 p.
 artikel
35 6IN SCLC CONSENSUS Le Pechoux, C.
 2011
 71 S2 p. S5-
1 p.
 artikel
36 28IN STEREOTACTIC BODY RADIOTHERAPY FOR PULMONARY OLIGOMETASTASES Lagerwaard, F.J.
 2011
 71 S2 p. S17-
1 p.
 artikel
37 27IN SURGERY FOR METASTATIC DISEASE TO THE LUNG Rocco, G.
 2011
 71 S2 p. S16-
1 p.
 artikel
38 43IN SURGERY – WHAT ARE THE REQUIREMENTS FOR A THORACIC ONCOLOGY CENTER? Passlick, B.
 2011
 71 S2 p. S25-
1 p.
 artikel
39 22IN TAKING ADVANTAGE OF INTRA-TUMOUR HETEROGENEITY De Ruysscher, D.
 2011
 71 S2 p. S14-
1 p.
 artikel
40 33IN THE CONCEPT OF NEUROENDOCRINE TUMORS Kerr, K.M.
 2011
 71 S2 p. S20-
1 p.
 artikel
41 18IN THE FUTURE OF SCREENING WITH MOLECULAR BIOLOGY, EXHALE BREATH ANALYSIS, ETC. Sozzi, G.
 2011
 71 S2 p. S11-
1 p.
 artikel
42 21IN THE POINT OF VIEW OF THE ONCOLOGIST Eberhardt, W.
 2011
 71 S2 p. S12-S13
2 p.
 artikel
43 20IN THE POINT OF VIEW OF THE RADIATION ONCOLOGIST Dziadziuszko, R.
 2011
 71 S2 p. S12-
1 p.
 artikel
44 19IN THE POINT OF VIEW OF THE SURGEON van Schil, P.
 2011
 71 S2 p. S12-
1 p.
 artikel
45 31IN THE ROLE OF SURGERY IN THE MANAGEMENT OF THYMOMAS: STATE OF THE ART Ruffini, E.
 2011
 71 S2 p. S18-S19
2 p.
 artikel
46 14IN TNM QUIZ Rami-Porta, R.
 2011
 71 S2 p. S9-
1 p.
 artikel
47 25IN VIDEO-ASSISTED MINIMAL INVASIVE LOBECTOMY: REALITY OR THE FUTURE? Hansen, H.J.
 2011
 71 S2 p. S15-
1 p.
 artikel
48 7IN WHAT CAN BE ACHIEVED WITH PRESENT PATHOLOGY? Kerr, K.M.
 2011
 71 S2 p. S6-
1 p.
 artikel
49 9IN WHAT CAN WE LEARN FROM CIRCULATING TUMOR CELLS, CIRCULATING DNA AND STEM CELLS? Blackhall, F.
 2011
 71 S2 p. S7-
1 p.
 artikel
50 40IN WHAT IS MAINTENANCE? TERMS AND CONCEPTS de Marinis, F.
 2011
 71 S2 p. S24-
1 p.
 artikel
51 26IN WHEN IS IT JUSTIFIED TO TREAT PULMONARY METASTASIS WITH LOCAL THERAPIES? WHICH ARE THE MOST FREQUENT METASTASES? Pfannschmidt, J.
 2011
 71 S2 p. S16-
1 p.
 artikel
52 15IN WHERE DO WE STAND ON SCREENING IN EUROPE? van Klaveren, R.J.
 2011
 71 S2 p. S10-
1 p.
 artikel
53 Keyword index 2011
 71 S2 p. S57-S58
2 p.
 artikel
54 98P ALTERNATIVE SYSTEM OF MEDICINES [CAM] & CANCER PATIENTS SURVIVAL: ARE WE READY TO CHANGE OUR THERAPEUTIC APPROACH? Shankpal, P.D.
 2011
 71 S2 p. S49-
1 p.
 artikel
55 97P A NEW 3D CONFORMATIONAL SOLUTION RADIOTHERAPY OF MALIGNANT PLEURAL MESOTHELIOMA Pedicini, P.
 2011
 71 S2 p. S48-
1 p.
 artikel
56 100P CASE REPORT: A GIANT DUMBBELL GANGLIONEUROMA OF THE POSTERIOR MEDIASTINUM Caushi, F.S.
 2011
 71 S2 p. S50-
1 p.
 artikel
57 70P CEREBELLAR ATAXIA CAUSED FROM METASTATIC INVOLVEMENT IN SMALL CELL LUNG CARCINOMA (SCLC) Hardavella, G.
 2011
 71 S2 p. S36-
1 p.
 artikel
58 47PD ANAPLASTIC LYMPHOMA KINASE (ALK) STATUS AND CLINICAL OUTCOMES BY IHC AND FISH: A RETROSPECTIVE STUDY OF NEVER-SMOKER, ADENOCARCINOMA LUNG CANCER CASES Yang, P.
 2011
 71 S2 p. S26-
1 p.
 artikel
59 60PD BONE METASTASES IN NSCLC: THE ANTIANGIOGENIC EFFECT OF ZOLEDRONIC ACID (ZA) Quirino, M.
 2011
 71 S2 p. S32-
1 p.
 artikel
60 68PD CHEMORADIOTHERAPY DURATION CORRELATES WITH OVERALL SURVIVAL IN LIMITED-DISEASE SMALL-CELL LUNG CANCER PATIENTS WITH POOR INITIAL PERFORMANCE STATUS WHO SUCCESSFULLY COMPLETED MULTIMODALITY TREATMENT Manapov, F.
 2011
 71 S2 p. S35-
1 p.
 artikel
61 90PD COMPARATIVE EFFICACY OF GEFITINIB AND OTHER RECOMMENDED REGIMENS FOR FIRST-LINE MANAGEMENT IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN SPAIN: A NETWORK META-ANALYSIS Verduyn, S.C.
 2011
 71 S2 p. S45-
1 p.
 artikel
62 78PD EARLY COMPLICATIONS AFTER PNEUMONECTOMY FOR NON SMALL CELL LUNG CARCINOMA: RETROSPECTIVE STUDY OF 168 PATIENTS Alloubi, I.
 2011
 71 S2 p. S40-
1 p.
 artikel
63 88PD EFFICACY AND SAFETY OF ERLOTINIB VERSUS CHEMOTHERAPY IN SECOND-LINE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) WITH POOR PROGNOSIS: THE PHASE III TITAN STUDY Ciuleanu, T.
 2011
 71 S2 p. S44-
1 p.
 artikel
64 48PD ERCC1 IS OVEREXPRESSED IN NON-SMALL CELL LUNG CARCINOMAS AS WELL AS IN ADJACENT HYPERPLASTIC REGIONS AND IS ASSOCIATED WITH LOW-DEGREE DIFFERENTIATION Koutsami, M.
 2011
 71 S2 p. S26-S27
2 p.
 artikel
65 92PD GEFITINIB EXPANDED ACCESS PROGRAM IN SWITZERLAND: REPORT OF LONG-TERM FOLLOW-UP Gautschi, O.
 2011
 71 S2 p. S45-S46
2 p.
 artikel
66 81PD IMPACT OF ADJUVANT CHEMOTHERAPY SEQUENCE ON BRAIN RELAPSE RATES IN PATIENTS WITH STAGE IIIB NON-SMALL CELL LUNG CARCINOMA TREATED WITH CONCURRENT CHEMORADIOTHERAPY PLUS PROPHYLACTIC CRANIAL IRRADIATION Pehlivan, B.
 2011
 71 S2 p. S41-
1 p.
 artikel
67 72PD LOBECTOMY IN COMBINATION WITH RADICAL LYMPHADENECTOMY IS THE MOST FREQUENT SURGICAL INTERVENTION PERFORMED IN PATIENTS RANDOMIZED IN MAGRIT TRIAL EVALUATING MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT TREATMENT IN STAGE IB IIIA NSCLC Zielinski, M.
 2011
 71 S2 p. S37-S38
2 p.
 artikel
68 89PD LONG-TERM SURVIVAL IN UNSELECTED PATIENTS TREATED WITH A PERSONALIZED SCHEDULE WITH ERLOTINIB Passaro, A.
 2011
 71 S2 p. S44-
1 p.
 artikel
69 58PD NANOSTRING MULTIPLE TARGET PROFILING IDENTIFIES AEG-1 AS AN ESSENTIAL PREDICTOR OF ERLOTINIB OUTCOME IN EGFR-MUTANT NON-SMALL-CELL LUNG CANCER (NSCLC) Rosell, R.
 2011
 71 S2 p. S31-
1 p.
 artikel
70 71PD NOT ONLY THE FINGERS: ROLE OF RADIO-GUIDED VIDEO-ASSISTED THORACIC SURGERY IN NON-PALPABLE SOLITARY PULMONARY NODULES Bertolaccini, L.
 2011
 71 S2 p. S37-
1 p.
 artikel
71 65P DOES PET-CT BASED CLINICAL STAGING OF NON-SMALL CELL LUNG CANCER OBVIATE INVASIVE PROCEDURES? Faber, D. Levy
 2011
 71 S2 p. S33-S34
2 p.
 artikel
72 80PD PROGNOSTIC IMPORTANCE OF GROSS TUMOR VOLUME DEFINED BY UTILIZING 18-FDG-PET/CT IN STAGE IIIB NON-SMALL CELL LUNG CARCINOMA TREATED WITH DEFINITIVE CHEMORADIOTHERAPY Parlak, C.
 2011
 71 S2 p. S40-S41
2 p.
 artikel
73 69PD RESPONSE OF PRIMARY THORACIC DISEASE TO CHEMORADIOTHERAPY CORRELATES WITH BRAIN-METASTASIS FREE SURVIVAL IN LIMITED-DISEASE SMALL-CELL LUNG CANCER PATIENTS WITH POOR INITIAL PERFORMANCE STATUS WHO SUCCESSFULLY COMPLETED MULTIMODALITY TREATMENT Manapov, F.
 2011
 71 S2 p. S35-
1 p.
 artikel
74 96PD RETROSPECTIVE REVIEW OF PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) Pérez, S.M. Cedrés
 2011
 71 S2 p. S48-
1 p.
 artikel
75 59PD SERUM LEVEL OF CC-CHEMOKINE LIGAND 18 (PULMONARY ACTIVATION-REGULATED CHEMOKINE) IN PATIENTS WITH NON SMALL CELL LUNG CANCER Pl¨ones, T.
 2011
 71 S2 p. S31-
1 p.
 artikel
76 61PD SERUM N-TELOPEPTIDE OF TYPE I COLLAGEN AND BONE ALKALINE PHOSPHATASE AND THEIR RELATIONSHIP IN PATIENT WITH NON-SMALL CELL LUNG CARCINOMA AND BONE METASTASES Lumachi, F.
 2011
 71 S2 p. S32-
1 p.
 artikel
77 91PD STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOMETASTATIC LUNG TUMORS Beltramo, G.
 2011
 71 S2 p. S45-
1 p.
 artikel
78 73PD STEREOTACTIC BODY RADIOTHERAPY FOR PRIMARY LUNG CANCER: A NON INVASIVE TREATMENT APPROACH IN MEDICALLY INOPERABLE PATIENTS Beltramo, G.
 2011
 71 S2 p. S38-
1 p.
 artikel
79 79PD THE ROLE OF SURGICAL RESECTION IN THE MULTIMODAL MANAGEMENT OF LOCALLY ADVANCED N2 NON-SMALL CELL LUNG CANCER. A SINGLE INSTITUTION'S EXPERIENCE Bosch-Barrera, J.
 2011
 71 S2 p. S40-
1 p.
 artikel
80 94P EFFECTIVENESS AND TOLERABILITY OF GEFITINIB IN METASTATIC NON SMALL CELL LUNG CARCINOMA AMONG SPECIFIC ASIAN POPULATION Thiruvenkatachari, M.
 2011
 71 S2 p. S46-S47
2 p.
 artikel
81 64P EFFECT OF CONTRAST MEDIUM ON IMAGE NOISE AND RADIATION DOSE IN ADULT CHEST COMPUTED TOMOGRAPHY USING AUTOMATIC EXPOSURE CONTROL: A COMPARATIVE STUDY BETWEEN 16-, 64- AND 128-SLICE CT Paul, J.
 2011
 71 S2 p. S33-
1 p.
 artikel
82 86P EFFICACY OF CONCURRENT CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER Almodovar, M.
 2011
 71 S2 p. S42-S43
2 p.
 artikel
83 63P ESTIMATION AND COMPARISON OF ORGAN AND EFFECTIVE DOSE (E) VALUES FOR CHEST CT EXAMINATIONS USING DIFFERENT APPROACHES AND ASSESSMENT OF THE INFLUENCE OF CT TUBE POTENTIAL (ENERGY DEPENDENTS) ON EFFECTIVE DOSE Paul, J.
 2011
 71 S2 p. S33-
1 p.
 artikel
84 104P EVALUATION OF CANCER-NGO'S PATIENT ADVOCACY PROJECT: PATH TO INCREASE SURVIVAL Shankpal, P.D.
 2011
 71 S2 p. S51-
1 p.
 artikel
85 62P G-CSF PRODUCING LUNG CANCER Matsuda, E.
 2011
 71 S2 p. S32-
1 p.
 artikel
86 56P INCIDENCE OF LUNG CANCER INCREASING IN SETIF, ALGERIA, 1986–2006 Zoubida, Z.Z.
 2011
 71 S2 p. S30-
1 p.
 artikel
87 85P INOPERABLE NON SMALL CELL LUNG CANCER TREATED WITH CHEMOTHERAPY AND SEQUENTIAL RADIOTHERAPY USING HELICAL TOMOTHERAPY Cianciulli, M.
 2011
 71 S2 p. S42-
1 p.
 artikel
88 83P INTEGRATED BOOST IMRT FOR LUNG CARCINOMA. THE INSTITUTIONAL EXPERIENCE OF IOSE CENTER, GRUPO IMO, MURCIA, SPAIN Fondevilla, A.
 2011
 71 S2 p. S41-S42
2 p.
 artikel
89 102P IS NEOADJUVANT CHEMO-RADIOTHERAPY A CONTRAINDICATION FOR MINIMALLY INVASIVE ESOPHAGECTOMY IN LOCALLY ADVANCED ESOPHAGEAL CANCER? A NEW EXPERIENCE IN THE UAE Elsherif, A.E.
 2011
 71 S2 p. S50-
1 p.
 artikel
90 50P LYMPHANGIOGENESIS IN SMALL CELL LUNG CARCINOMAS (SCLC); NEW INSIGHTS IN PROGNOSIS Hardavella, G.
 2011
 71 S2 p. S27-
1 p.
 artikel
91 95P MEDIASTINOSCOPIC APPROACH FOR LUNG BIOPSY IN BRONCHOPULMONARY CANCER Bobocea, A.C.
 2011
 71 S2 p. S47-
1 p.
 artikel
92 49P MULTIPLEX ANALYSIS OF A PANEL OF BONE REMODELLING SERUM MARKERS IN PATIENTS WITH BONE METASTASES FROM LUNG CANCER Lumachi, F.
 2011
 71 S2 p. S27-
1 p.
 artikel
93 103P NEPHROBLASTOMA (WILMS TUMOR) IN AN ADULT PRESENTING WITH LUNG METASTASES Hardavella, G.
 2011
 71 S2 p. S51-
1 p.
 artikel
94 87P ORAL GLUTAMINE SUPPLEMENTATION HAS NO NEGATIVE IMPACT ON SURVIVAL IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY Topkan, E.
 2011
 71 S2 p. S43-
1 p.
 artikel
95 52P PRIMARY EWING'S SARCOMA/PERIPHERAL NEURO- ECTODERMAL TUMORS ARISING FROM THE LUNG OF AN ADULT MALE Mariano, M.
 2011
 71 S2 p. S28-
1 p.
 artikel
96 57P PRIMARY LUNG CANCER WITH A THIN-WALLED CAVITY Jung, C.Y.
 2011
 71 S2 p. S30-
1 p.
 artikel
97 51P PRIMARY SYNOVIAL SARCOMA OF THE LUNG: A CASE REPORT CONFIRMED BY MOLECULAR DETECTION OF SYT SSX FUSION GENE TRANSCRIPTS Payandeh, M.
 2011
 71 S2 p. S27-S28
2 p.
 artikel
98 82P RADIOBIOLOGICAL ANALYSIS OF MODIFIED FRACTIONATIONS IN IMRT OF NON SMALL CELL LUNG CANCER Pedicini, P.
 2011
 71 S2 p. S41-
1 p.
 artikel
99 99P RECOMMENDATIONS FOR IMPROVING QOL IN LUNG CANCER PATIENTS: INTEGRATED APPROACH INVOLVING CANCER MSW/NURSE AND PALLIATIVE CARE TEAM Shankpal, V.P.
 2011
 71 S2 p. S49-S50
2 p.
 artikel
100 93P RETROSPECTIVE ANALYSIS OF SYSTEMIC TREATMENT IN PATIENTS WITH POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA OF THE LUNG. 10-YEAR RARE TUMORS GROUP EXPERIENCE Martinez-Martinez, G.
 2011
 71 S2 p. S46-
1 p.
 artikel
101 101P SHORT-TERM RESULTS OF SURGICAL RESECTION OF PULMONARY METASTASES FROM COLORECTAL AND NONCOLORECTAL CANCERS Lumachi, F.
 2011
 71 S2 p. S50-
1 p.
 artikel
102 74P STEREOTACTIC BODY IRRADIATION IN PATIENTS WITH T1-T2 NSCLC OR LUNG METASTASES FROM DIFFERENT PRIMARY SITES: PRELIMINARY RESULTS Marcenaro, M.
 2011
 71 S2 p. S38-
1 p.
 artikel
103 75P STEREOTACTIC RADIOTHERAPY FOR LUNG CANCER: EARLY EFFICACY AND TOXICITY EVALUATION OF A NON-INVASIVE REAL-TIME TUMOR TRACKING SYSTEM Bibault, J.
 2011
 71 S2 p. S38-S39
2 p.
 artikel
104 66P THE FEASIBILITY OF ROUTINE MEDICAL THORACOSCOPY FOR THE DETECTION OF MALIGNANT EFFUSION IN THE DIAGNOSIS OF UNDETERMINED PLEURAL EFFUSION Kim, D.H.
 2011
 71 S2 p. S34-
1 p.
 artikel
105 76P THE IMPACT OF A BREATHING-CONTROL SYSTEM ON TARGET MARGINS AND NORMAL TISSUE SPARING IN THE TREATMENT OF LUNG CANCER: ANALYSIS OF 12 CASES AT RADIOTHERAPY UNIT OF FLORENCE UNIVERSITY Scotti, V.
 2011
 71 S2 p. S39-
1 p.
 artikel
106 77P THE PROGNOSTIC ROLE OF GLUCOSE-CORRECTED MAXIMUM STANDARDIZED UPTAKE VALUE (GC-SUVMAX) IN EARLY RECURRENCE RISK OF NON-SMALL CELL LUNG CANCER (NSCLC) AFTER COMPLETE RESECTION Konings, R.
 2011
 71 S2 p. S39-
1 p.
 artikel
107 54P THE RISK OF LIFELONG DNA DAMAGE CAUSED BY LUNG CANCER AMONG RURAL MALE SMOKERS WHO BEGIN AT TEENAGE Odiase, E.O.
 2011
 71 S2 p. S29-
1 p.
 artikel
108 55P THE RISK OF TOBACCO-SPECIFIC LUNG CARCINOGEN AMONGST NON-SMOKING RESTAURANT AND BAR WORKERS IN NIGERIA Odiase, E.O.
 2011
 71 S2 p. S29-S30
2 p.
 artikel
109 53P THE VALIDATION OF FIBRIN AND FIBRINOGEN DEGREDATION PRODUCTS ASSAY FOR EARLY DETECTION OF LUNG CANCER Motamed-Khorasani, A.
 2011
 71 S2 p. S29-
1 p.
 artikel
110 67P UNDETECTED SMALL NODULE OF ADENOCARCINOMA OF THE LUNG PRESENTING WITH BONE METASTASES AND A BIG MASS IN THE LIVER MISDIAGNOSED AS LIVER CANCER Gondhowiardjo, S.
 2011
 71 S2 p. S34-
1 p.
 artikel
111 84P VALUE OF CURATIVE TREATMENT CHEMOTHERAPY AND RADIOTHERAPY VERSUS PALLIATIVE RADIOTHERAPY ALONE IN THE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER Dzhugashvili, M.
 2011
 71 S2 p. S42-
1 p.
 artikel
112 The European Respiratory Society (ERS) 2011
 71 S2 p. xiii-
1 p.
 artikel
113 The European Society for Medical Oncology (ESMO) 2011
 71 S2 p. vii-
1 p.
 artikel
114 The European Society for Therapeutic Radiology and Oncology (ESTRO) 2011
 71 S2 p. ix-
1 p.
 artikel
115 The European Society of Thoracic Surgeons (ESTS) 2011
 71 S2 p. xi-
1 p.
 artikel
116 The European Thoracic Oncology Platform (ETOP) 2011
 71 S2 p. xi-
1 p.
 artikel
117 Translational research reference list 2011
 71 S2 p. S61-
1 p.
 artikel
                             117 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland